Andrew Hexter – Vice President & General Manager Asia…
Andrew Hexter, VP and GM of Gilead Asia 5 (Hong Kong, Singapore, South Korea, Taiwan and Malaysia), shares the highlights of his past three years…
Tagged with Hong Kong
HKEX SVP Reflects on Two Years of Pre-Revenue Biotech IPO…
It has been just over two years since the Hong Kong Stock Exchange (HKEX) revised its listing rules to allow pre-revenue biotechs to IPO as long as…
Hong Kong Biotech IPOs since Listing Reform in April 2018
On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…
Precision Medicine in Asia: More Regional Cooperation Needed
With Asia covering 60 percent of the world’s population but accounting for just around 30 percent of global pharma spending, it goes without saying…
Alex Wong – CEO, Xcelom
Alex Wong, CEO of Xcelom sat down with PharmaBoardroom to discuss the company’s non-invasive prenatal testing (NIPT) technology and increasing…
Albert Yu – Chairman, Hong Kong Biotechnology Organization…
Dr Albert Yu, chairman of the Hong Kong Biotechnology Organization (HKBIO) gives his expert insights into the crucial importance of diagnostics in…
Alex Zhavoronkov – CEO, Insilico Medicine
Alex Zhavoronkov, CEO of Insilico Medicine, lifts the lid on the role of AI in target discovery, identification, and validation. He also offers his…
Desmond Hau – CEO, Pangenia Group
Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…
Kelvin Chiu – CEO & Isabelle Dutry – CSO, Sanwa…
Kelvin Chiu and Isabelle Dutry of Sanwa BioTech in Hong Kong highlight the critical importance of personalised fast-track diagnostics in countering…
Michael Chan – Senior Vice President, Global Issuer…
Michael Chan, Senior Vice President of Global Issuer Services for the Hong Kong Exchange (HKEX) highlights the vibrancy and diversity that biotechs…
Xu Ting – Founder, Chairman & CEO, Alphamab Oncology,…
PharmaBoardroom caught up with Alphamab Oncology’s founder, chairman and CEO Dr Xu Ting again 16 months after our last interview to hear about their…
Chinese Biotechs Flock to IPO in Hong Kong
2019 was a bumper year for biotech companies listing on the Hong Kong Exchange (HKEx), with nine pre-revenue biotechs and eight revenue-generating…
